Fig 1: Hepatic ACE2 and TMPRSS2 according to the amount of steatosis (a–d) and to the degree of NAS score (e,f). ACE2, angiotensin converting enzyme 2; NAS, non-alcoholic fatty liver disease activity score; TMPRSS2, transmembrane serine pro-tease 2.
Fig 2: Flow chart of the study. ACE2, angiotensin converting enzyme 2; CHB, chronic hepatitis B; CHC, chronic hepatitis C; NAFLD, non-alcoholic fatty liver disease; SARS-Cov-2, severe acute respiratory coronavirus virus 2; TMPRSS2, transmembrane serine protease 2.
Fig 3: Immunohistochemistry staining for ACE2 (a), and TMPRSS2 (b), images have been taken at 10× magnification. White arrowheads show ACE2 expression in a cirrhotic patient liver. Inset at 20× magnification highlights ACE2-positivity (brown). ACE2, angiotensin converting enzyme 2; Contr, control; TMPRSS2, transmembrane serine pro-tease 2. Cases 1 = Cirrhosis; Cases 2,3 = F0; Cases 4–6 = F3.
Supplier Page from Abcam for Human TMPRSS2 ELISA Kit